Skip to content

PolitiKit

Lobbying by Emergent BioSolutions Canada Inc.: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.

← Lobbying

Client of a consultant lobbyist

Emergent BioSolutions Canada Inc.

Meetings this Parliament
0
With MPs
0
Since Nov 2021
13
Active registrations
1

Most recent reported meeting: Jan 29, 2025.

Registrations in effect

Consultant In effect since Aug 8, 2026

Consultant Sheamus Murphy of Counsel Public Affairs Inc.

Consultant lobbyists

  • Sheamus Murphy Former public office holder

    Formerly Manager of Communications, House of Commons, Liberal Research Bureau (2009–2011)

  • Sheamus Murphy Former public office holder

    Formerly Manager of Communications, House of Commons, Liberal Research Bureau (2009–2011)

  • Sheamus Murphy Former public office holder

    Formerly Manager of Communications, House of Commons, Liberal Research Bureau (2009–2011)

Institutions they may lobby: Canada Revenue Agency (CRA), Correctional Service of Canada (CSC), Health Canada (HC), House of Commons, Indigenous Services Canada (ISC), Innovation, Science and Economic Development Canada (ISED), National Defence (DND), Prairies Economic Development Canada (PrairiesCan), Prime Minister's Office (PMO), Public Health Agency of Canada (PHAC), Public Safety Canada (PS), Royal Canadian Mounted Police (RCMP), Senate of Canada, Veterans Affairs Canada (VAC)

What they're lobbying on (8)
  • Engagement as part of the federal pre-budget consultation process regarding supply chain priorities, challenges and recommendation for consideration in the 2026 budget
  • Discuss changes to take home naloxone program.
  • Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats.
  • Engage Health and National Defence concerning Emergent's Winnipeg facility for the production of medical countermeasures.
  • Engage National Defence, Health, and Global Affairs Canada on national readiness in response to emerging global health threats.
  • To work with government to make NARCAN® (Naloxone HCI) Nasal Spray more widely available across Canada to facilitate immediate treatment to individuals suffering from opioid overdose.
  • Seek funding support from the Strategic Innovation Fund to expand Emergent's Winnipeg facility.
  • Eligibility for Scientific Research and Experimental Development tax incentives.

Registration 923002-359779-17. Look it up in the official Registry

Reported meetings

Spreadsheet

  • Reported by Sheamus Murphy · Consultant

    • Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
    To work with government to make NARCAN® (Naloxone HCI) Nasal Spray more widely available across Canada to facilitate immediate treatment to individuals suffering from opioid overdose. Read more

    Engage government regarding the need for sustainable manufacturing, procurement and stockpiling of medical countermeasures used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear threats.

    Official report

  • Reported by Sheamus Murphy · Consultant

    • Joanna Lam · Policy and Regional Affairs Advisor, Indigenous Services Canada (ISC)
    Discuss changes to take home naloxone program.

    Official report

  • Reported by Sheamus Murphy · Consultant

    • Eshan Naik · Director of Policy, Health Canada (HC)
    To work with government to make NARCAN® (Naloxone HCI) Nasal Spray more widely available across Canada to facilitate immediate treatment to individuals suffering from opioid overdose. Read more

    Engage Health and National Defence concerning Emergent's Winnipeg facility for the production of medical countermeasures.

    Official report

  • Reported by Sheamus Murphy · Consultant

    • Jordano Nudo · Deputy Director of Policy, Indigenous Services Canada (ISC)
    • Joanna Lam · Policy and Regional Affairs Advisor, Indigenous Services Canada (ISC)
    To work with government to make NARCAN® (Naloxone HCI) Nasal Spray more widely available across Canada to facilitate immediate treatment to individuals suffering from opioid overdose. Read more

    Official report

  • Reported by Sheamus Murphy · Consultant

    • Larysa Lubka-Lewyckyj · Senior Policy Advisor, National Defence (DND)
    • Hilary Hendricks · Policy Advisor, National Defence (DND)

    DefenceGovernment ProcurementNational Security/SecurityNatural ResourcesScience and Technology

    Official report

  • Reported by Sheamus Murphy · Consultant

    • Joanna Lam · Policy and Regional Affairs Advisor, Indigenous Services Canada (ISC)

    Aboriginal AffairsGovernment ProcurementHealth

    Official report

  • Reported by Sheamus Murphy · Consultant

    Government ProcurementHealth

    Official report

  • Reported by Sheamus Murphy · Consultant

    • Bianca Hossain · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)

    Government ProcurementHealth

    Official report

  • Reported by Sheamus Murphy · Consultant

    • Boyan Gerasimov · Director of Policy, Innovation, Science and Economic Development Canada (ISED)

    Government ProcurementHealth

    Official report

  • Reported by Sheamus Murphy · Consultant

    • Bianca Hossain · Sr Special Assistant, Innovation, Science and Economic Development Canada (ISED)
    • Ekateryna Nova · Regional Advisor, Innovation, Science and Economic Development Canada (ISED)

    Government ProcurementHealth

    Official report

  • Reported by Sheamus Murphy · Consultant

    • Bradley Boudreau · Policy Advisor, Crown-Indigenous Relations and Northern Affairs Canada (CIRNAC)

    Government ProcurementHealth

    Official report

  • Reported by Sheamus Murphy · Consultant

    • Bianca Houssain · Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
    • Ekateryna Nova · Regional Advisor, Innovation, Science and Economic Development Canada (ISED)

    Government ProcurementHealth

    Official report

  • Reported by Sheamus Murphy · Consultant

    • Julia Duncan · Senior Policy Advisor, Health Canada (HC)

    Health

    Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.